Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29
U.K. (FTSE) Biotech Industry Analysis
UpdatedMay 10, 2024
DataAggregated Company Financials
Companies26
- 7D3.7%
- 3M-7.3%
- 1Y-23.4%
- YTD-9.3%
In the last week, the Biotech industry is up 3.7%, with Genus up 6.1%. In the same time, Avacta Group was down 7.5%. In contrast, the industry has lost 23% in the last 12 months. Earnings are forecast to grow by 27% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | UK£3.0b | UK£836.3m | -UK£299,943,178.08 | 31.7x | -10x | 3.6x |
| Sun, 07 Apr 2024 | UK£3.0b | UK£902.4m | -UK£200,893,434.97 | 28.7x | -15.2x | 3.4x |
| Tue, 05 Mar 2024 | UK£3.0b | UK£897.8m | -UK£203,769,065.75 | 32.1x | -14.5x | 3.3x |
| Thu, 01 Feb 2024 | UK£6.4b | UK£1.3b | -UK£245,416,079.00 | 38.2x | -26.2x | 5.1x |
| Sat, 30 Dec 2023 | UK£6.4b | UK£1.3b | -UK£245,117,058.00 | 38.8x | -26.1x | 5x |
| Mon, 27 Nov 2023 | UK£6.3b | UK£1.3b | -UK£245,852,859.00 | 37.1x | -25.5x | 4.9x |
| Wed, 25 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,175,705.00 | 39.2x | -25.8x | 5.1x |
| Fri, 22 Sep 2023 | UK£6.6b | UK£1.3b | -UK£223,116,528.00 | 23.6x | -29.8x | 5.2x |
| Sun, 20 Aug 2023 | UK£6.6b | UK£1.3b | -UK£207,866,392.00 | 23.6x | -31.8x | 5.3x |
| Tue, 18 Jul 2023 | UK£6.7b | UK£1.3b | -UK£207,491,946.00 | 23.9x | -32.4x | 5.3x |
| Thu, 15 Jun 2023 | UK£7.0b | UK£1.3b | -UK£205,458,930.00 | 22.9x | -33.9x | 5.5x |
| Sat, 13 May 2023 | UK£6.9b | UK£1.3b | -UK£206,769,274.00 | 23.8x | -33.5x | 5.5x |
| Mon, 10 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,069,522.00 | 24.2x | -46.6x | 5.8x |
| Wed, 08 Mar 2023 | UK£7.6b | UK£1.2b | -UK£157,198,605.00 | 26.8x | -48.2x | 6.1x |
| Fri, 03 Feb 2023 | UK£7.5b | UK£1.2b | -UK£146,941,521.00 | 26.5x | -51.2x | 6.5x |
| Sun, 01 Jan 2023 | UK£7.5b | UK£1.2b | -UK£141,349,221.00 | 27.1x | -52.9x | 6.4x |
| Tue, 29 Nov 2022 | UK£8.1b | UK£1.2b | -UK£139,491,980.00 | 24.4x | -58x | 7x |
| Thu, 27 Oct 2022 | UK£7.3b | UK£1.2b | -UK£148,560,244.00 | 22.7x | -48.9x | 6.2x |
| Sat, 24 Sep 2022 | UK£7.2b | UK£1.2b | -UK£174,377,705.00 | 26.4x | -41.4x | 6.2x |
| Mon, 22 Aug 2022 | UK£7.6b | UK£1.1b | -UK£203,058,399.00 | 37.1x | -37.2x | 6.8x |
| Wed, 20 Jul 2022 | UK£6.8b | UK£1.1b | -UK£202,968,472.00 | 34.1x | -33.4x | 6.1x |
| Fri, 17 Jun 2022 | UK£6.5b | UK£1.1b | -UK£158,316,005.00 | 35.3x | -41.1x | 5.9x |
| Sun, 15 May 2022 | UK£6.9b | UK£1.1b | -UK£146,427,737.00 | 36.6x | -47.1x | 6.2x |
| Tue, 12 Apr 2022 | UK£7.6b | UK£1.1b | -UK£91,952,690.00 | 40.6x | -82.3x | 6.9x |
| Thu, 10 Mar 2022 | UK£7.4b | UK£1.1b | -UK£134,944,517.00 | 33.6x | -55x | 6.9x |
| Sat, 05 Feb 2022 | UK£8.9b | UK£1.1b | -UK£119,969,127.00 | 38.6x | -74.3x | 8.2x |
| Mon, 03 Jan 2022 | UK£11.5b | UK£1.1b | -UK£120,779,727.00 | 57.3x | -94.9x | 10.6x |
| Wed, 01 Dec 2021 | UK£11.2b | UK£1.1b | -UK£123,128,363.00 | 61.3x | -90.9x | 10.3x |
| Fri, 29 Oct 2021 | UK£11.7b | UK£1.1b | -UK£136,274,674.00 | 69.3x | -86x | 10.8x |
| Sun, 26 Sep 2021 | UK£12.3b | UK£1.1b | -UK£118,788,788.00 | 69.7x | -103.2x | 11.1x |
| Tue, 24 Aug 2021 | UK£12.4b | UK£1.0b | -UK£172,541,949.91 | 31.5x | -71.6x | 12.1x |
| Wed, 30 Jun 2021 | UK£11.2b | UK£1.0b | -UK£172,541,949.91 | 30.1x | -65x | 11x |
Price to Earnings Ratio
-68.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.4x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.3% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 2.26% | |
| Healthcare | 2.07% | |
| Biotech | 3.67% | |
| Biotech | 3.67% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GNS Genus | UK£18.92 | 6.1% +UK£70.8m | -27.3% | PE37.1x | |
| PRTC PureTech Health | UK£2.23 | 4.2% +UK£24.3m | 7.0% | PS226.8x | |
| OXB Oxford Biomedica | UK£3.20 | 6.7% +UK£20.0m | -21.6% | PS3.6x | |
| 4BB 4basebio | UK£11.45 | 6.0% +UK£8.3m | 92.4% | PS414.2x | |
| SCLP Scancell Holdings | UK£0.097 | 6.6% +UK£4.9m | -39.4% | PE-8.3x |